Profile | GDS5420 / 235077_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 68.41 | 36 |
GSM1296119 | B_lesional_pre-dose | 73.62 | 35 |
GSM1296076 | C_lesional_pre-dose | 40.55 | 27 |
GSM1296092 | D_lesional_pre-dose | 38.72 | 29 |
GSM1296103 | E_lesional_pre-dose | 22.14 | 20 |
GSM1296078 | F_lesional_pre-dose | 40.05 | 28 |
GSM1296107 | G_lesional_pre-dose | 50.82 | 29 |
GSM1296109 | H_lesional_pre-dose | 84.87 | 37 |
GSM1296080 | I_lesional_pre-dose | 20.01 | 19 |
GSM1296090 | J_lesional_pre-dose | 101.66 | 43 |
GSM1296074 | K_lesional_pre-dose | 23.42 | 21 |
GSM1296111 | L_lesional_pre-dose | 161.59 | 48 |
GSM1296099 | M_lesional_pre-dose | 114.34 | 43 |
GSM1296086 | O_lesional_pre-dose | 38.48 | 28 |
GSM1296117 | P_lesional_pre-dose | 68.24 | 33 |
GSM1296113 | Q_lesional_pre-dose | 72.33 | 32 |
GSM1296096 | R_lesional_pre-dose | 47.19 | 31 |
GSM1296105 | S_lesional_pre-dose | 102.09 | 41 |
GSM1296098 | T_lesional_pre-dose | 110.98 | 42 |
GSM1296101 | U_lesional_pre-dose | 56.3 | 32 |
GSM1296121 | V_lesional_pre-dose | 85.19 | 38 |
GSM1296088 | W_lesional_pre-dose | 58.75 | 34 |
GSM1296082 | X_lesional_pre-dose | 34.9 | 27 |
GSM1296115 | Y_lesional_pre-dose | 69.16 | 34 |
GSM1296084 | Z_lesional_pre-dose | 52.61 | 31 |
GSM1296072 | B_lesional_day8 | 51.39 | 29 |
GSM1296069 | L_lesional_day8 | 312.36 | 59 |
GSM1296071 | P_lesional_day8 | 174.17 | 48 |
GSM1296070 | Y_lesional_day8 | 134.55 | 43 |
GSM1296073 | V_lesional_day8 | 67.85 | 34 |
GSM1296034 | A_lesional_day15 | 122.88 | 43 |
GSM1296041 | G_lesional_day15 | 62.85 | 32 |
GSM1296035 | R_lesional_day15 | 61.07 | 35 |
GSM1296038 | U_lesional_day15 | 55.77 | 33 |
GSM1296047 | B_lesional_day15 | 94.49 | 38 |
GSM1296039 | E_lesional_day15 | 31.43 | 24 |
GSM1296042 | H_lesional_day15 | 115.55 | 41 |
GSM1296043 | L_lesional_day15 | 415.05 | 64 |
GSM1296037 | M_lesional_day15 | 199.92 | 52 |
GSM1296046 | P_lesional_day15 | 118.21 | 41 |
GSM1296044 | Q_lesional_day15 | 95.53 | 38 |
GSM1296045 | Y_lesional_day15 | 122.16 | 41 |
GSM1296025 | C_lesional_day15 | 77.39 | 38 |
GSM1296033 | D_lesional_day15 | 78.39 | 38 |
GSM1296027 | I_lesional_day15 | 70.81 | 39 |
GSM1296032 | J_lesional_day15 | 96.79 | 41 |
GSM1296024 | K_lesional_day15 | 114.05 | 44 |
GSM1296031 | W_lesional_day15 | 215.02 | 53 |
GSM1296028 | X_lesional_day15 | 34.61 | 26 |
GSM1296029 | Z_lesional_day15 | 93.41 | 41 |
GSM1296026 | F_lesional_day15 | 183.35 | 52 |
GSM1296030 | O_lesional_day15 | 67.58 | 38 |
GSM1296040 | S_lesional_day15 | 144.93 | 47 |
GSM1296036 | T_lesional_day15 | 49.52 | 29 |
GSM1296048 | V_lesional_day15 | 207.61 | 53 |
GSM1296059 | A_lesional_day43 | 102.04 | 42 |
GSM1296066 | G_lesional_day43 | 101.51 | 39 |
GSM1296060 | R_lesional_day43 | 63.48 | 35 |
GSM1296063 | U_lesional_day43 | 66.74 | 35 |
GSM1296064 | E_lesional_day43 | 66.86 | 36 |
GSM1296067 | H_lesional_day43 | 195.73 | 50 |
GSM1296062 | M_lesional_day43 | 56.97 | 33 |
GSM1296068 | Q_lesional_day43 | 130.56 | 42 |
GSM1296050 | C_lesional_day43 | 105.01 | 42 |
GSM1296057 | D_lesional_day43 | 113.64 | 43 |
GSM1296052 | I_lesional_day43 | 135.75 | 48 |
GSM1296054 | J_lesional_day43 | 119.83 | 44 |
GSM1296049 | K_lesional_day43 | 98.68 | 41 |
GSM1296055 | W_lesional_day43 | 360.31 | 62 |
GSM1296053 | X_lesional_day43 | 62.07 | 34 |
GSM1296058 | Z_lesional_day43 | 121.23 | 45 |
GSM1296051 | F_lesional_day43 | 97.47 | 42 |
GSM1296056 | O_lesional_day43 | 34.9 | 27 |
GSM1296065 | S_lesional_day43 | 89.06 | 39 |
GSM1296061 | T_lesional_day43 | 84.14 | 38 |
GSM1296095 | A_non-lesional_pre-dose | 77.86 | 38 |
GSM1296120 | B_non-lesional_pre-dose | 64.57 | 32 |
GSM1296077 | C_non-lesional_pre-dose | 48 | 31 |
GSM1296093 | D_non-lesional_pre-dose | 111.06 | 42 |
GSM1296104 | E_non-lesional_pre-dose | 82.23 | 38 |
GSM1296079 | F_non-lesional_pre-dose | 73.83 | 37 |
GSM1296108 | G_non-lesional_pre-dose | 85.84 | 37 |
GSM1296110 | H_non-lesional_pre-dose | 109.72 | 40 |
GSM1296081 | I_non-lesional_pre-dose | 94.76 | 42 |
GSM1296091 | J_non-lesional_pre-dose | 37.03 | 28 |
GSM1296075 | K_non-lesional_pre-dose | 52.25 | 32 |
GSM1296112 | L_non-lesional_pre-dose | 172.08 | 47 |
GSM1296100 | M_non-lesional_pre-dose | 144.04 | 46 |
GSM1296087 | O_non-lesional_pre-dose | 66.23 | 38 |
GSM1296118 | P_non-lesional_pre-dose | 173.31 | 48 |
GSM1296114 | Q_non-lesional_pre-dose | 134 | 44 |
GSM1296097 | R_non-lesional_pre-dose | 93.66 | 40 |
GSM1296106 | S_non-lesional_pre-dose | 140.42 | 45 |
GSM1296102 | U_non-lesional_pre-dose | 90.12 | 39 |
GSM1296122 | V_non-lesional_pre-dose | 137.41 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 157.7 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 100.99 | 42 |
GSM1296116 | Y_non-lesional_pre-dose | 108.08 | 39 |
GSM1296085 | Z_non-lesional_pre-dose | 62.52 | 34 |